|
|
|
Higher Pregnancy rates with a simple method for Fallopian Tube Sperm Perfusion, using the Cervical Clamp Double Nut Bivalve Speculum in the treatment of unexplained infertility : A prospective randomised study. Leon Mamas “Mitera” Maternity and Surgical Hospital, 6 Er. Stavrou, St., Marousi 151 23, Athens, Greece. Correspondence should be addressed at: 8 Ethn. Makariou Street 154 52 P. Psichico, Athens, Greece Published in Human Reproduction Journal (www.humrep.oxfordjournals.org) The object of this study was to evaluate the efficacy of the newly developed cervical clamp Double Nut Speculum used for Fallopian tube Sperm Perfusion (FSP) with 4 ml of the inseminate, in comparison with standard Intrauterine Insemination (IUI) using a volume of 0,5 ml of the inseminate. A hundred and four (104) couples with unexplained infertility, undergoing 202 cycles, were enrolled in this study, assigned randomly to either IUI (group A, n=92) or FSP + DNB Speculum® (group B, n=110). Controlled ovarian stimulation was achieved by using three different ovarian stimulation protocols in both groups. The age of the patients was almost similar in both groups, as well as the follicular development. The serum hormonal measurements and the endometrial thickness was also similar on the day of human chorionic gonadotrophin (HCG) administration. The mean (± SD) number of motile spermatozoa inseminated was 44.83 ± 16.57 × 106 in group A and 42.68 ± 13.44 × 106 in group B. In group A (IUI), 11 clinical pregnancies (presence of gestational sac with heart beats) occurred (11.95% per cycle ). In group B (FSP + DNB Speculum®) 29 clinical pregnancies occurred (26.36% per cycle). These differences were statistically significant (P<0.001). The results of this study for the treatment of unexplained infertility indicate that this simple, well tolerated, inexpensive method of using the cervical clamp Double Nut Bivalve Speculum (DNB Speculum®) for fallopian tube sperm perfusion (FSP) is more successful than standard intrauterine insemination (IUI). Key words: Cervical clamp Double Nut Bivalve Speculum (DNB Speculum®) / Fallopian tube Sperm Perfusion (FSP) / Intrauterine Insemination (IUI) / ovarian stimulation / unexplained infertility. Introduction Intrauterine insemination with mild ovarian stimulation has in recent years been a popular method with a great interest in the treatment of unexplained infertility. The fecundity reported in the literature ranged from 5,7% to 17,7% per cycle (Allen et al., 1985; Chaffkin et al., 1991; Dodson and Hanney, 1991; Balasch et al., 1994; Ombelet et al., 1995 Campana et al., 1996). Although the number of available oocytes increase by the ovarian stimulation to 3-4 or even more, the results are still not very promising, mainly because of low sperm count, suboptimal spermatozoa or total absence of spermatozoa at the site of fertilization. Mortimer and Templeton (1982) showed that there is a reduction in sperm number of five to six orders of magnitude along the length of female reproductive tract. Even, when all the characteristics of semen were normal, there was still only a 49% chance of spermatozoa being found in the peritoneal cavity. However, significantly greater numbers of peritoneal spermatozoa have been found after artificial insemination into the external os, rather than after intercourse. Another study (Ripps et al., 1994) showed that the number of spermatozoa recovered in the peritoneal fluid at laparoscopy after IUI was very low, however the number was increasing after utero-tubal flushes. Utero-tubal flushes required a certain intrauterine perfusion pressure for the achievement of spill in normal tubes or in tubes with minimal adhesions (Baker and Adamson. 1995). In the mid follicular phase and before ovulation the endometrial glandural lumen of the fallopian tube is narrow and contains some quantities of granular and membranous material, as well as increasing amounts of cytoplasmic debris and cellular fragments ( Amso et al., 1994). A partial tubal luminal obstruction may also be due to the presence of tubal ostium membranes (Coeman et al., 1995). Various methods for increasing the number of spermatozoa in the fallopian tubes at the time of ovulation were invented and tried with encouraging results. However, these are invasive, laparoscopic (Berger, 1987) or less invasive transcervical methods with the possibility of adverse effects, namely trauma, infection, and vasovagal episodes. For these reasons the relative benefits of the above mentioned approaches have been questioned (Lucena et al., 1989; Pratt et al., 1991, Oei et al.,1992). Recently, other non invasive methods were introduced, simpler, not requiring catheterization. These methods were based on a certain injection pressure needed in order to enable the 4 ml of sperm suspension, after filling the uterine cavity with the volume of 0.4ml (Franco et al., 1992), to pass through the interstitial part of the tube and, finally, reach the ampulla and the Pouch of Douglas (Gleicher et al., 1992). These methods require an appropriate cervical seal which will prevent sperm leakage into the vagina during uterotubal perfusion, which otherwise occurs mainly because of the opening of the cervical canal due to ovulation. Kahn et al., 1992, 1993a, 1993b, described a method of fallopian tube sperm perfusion using an Allis clamp placed on the cervix. However, this clamping of the cervix produced some discomfort or even pain and occasionally bleeding from the cervix. Another method was described by Li, T.C., 1993. This author used a Foley size 8 pediatric catheter with the balloon inflated in the uterine cavity to seal the uterocervical junction. However, introducing the Foley catheter through the cervix presented some difficulties, mainly because of its flexibility, especially in nulliparous patients who constitute the majority. The use of forceps was necessary to provide steady downward traction on the cervix which served to reduce the angle between the uterine cavity and the cervical canal. The discomfort and the possible endometrial injury caused by the compressive effect of the balloon are some of the disadvantages of this method. More recently, another method for Fallopian tube sperm perfusion has been proposed (Fanchin et al., 1995a) using the Fallopian Sperm Transfer System (FAST System ®, CCD Laboratories, Paris, France) with pregnancy results twice as high as standard IUI, but in some cases sperm reflux was noticed, due to a deficient adjustment of the acorne tip of the devise to the external cervical os. The presence of another person was also necessary to assist in handling the syringe adapted to the vacuum valve. To surmount the main failings of these methods, a speculum with specially modified tips was designed to fit around the cervix, allowing also easy grasping of the cervix and firm clamping of the cervical canal for the prevention of leakage or reflux during and after the intrauterine insemination for fallopian tube sperm perfusion. The use of this cervical clamp Double Nut Bivalve Speculum (DNB Speculum®, Parthenon Medical Ltd, Athens, Greece) results in a most satisfactory higher sperm perfusion. It is a simple method, non invasive, well tolerated, without any discomfort or bleeding and quite inexpensive (Mamas, L., 1995a, 1995b). A prospective randomized trial comparing results of Fallopian tube Sperm Perfusion using the DNB speculum ®, versus standard IUI is reported here. Materials and methods Patient selection During the 8-month period from October 1, 1995, to May 31, 1996 a hundred and four (104) couples undergoing 202 cycles, were referred to the Sperm Laboratory of the hospital. They were asked whether they would like to participate in this study. All couples suffered from unexplained infertility and had regular menstrual cycles 25-33 days. Spontaneous ovulation was checked by vaginal ultrasound and normal serum progesterone concentrations by midluteal phase serum (P > 10 ng/ml). Serum levels of follicle stimulating hormone, luteinizing hormone, prolactin, testosterone, sex hormone-binding globulin had to be in the normal range. The mean duration of infertility was 3.94 ± 1.25 years (2-8) for group A, and 3.90 ± 1.24 years (2-8) for group B. Patients had to be younger than 39 years old. All patients had undergone hysterosalpingogram or hysterosalpingogram, laparoscopy and hysteroscopy in the last 12 months before insemination and had had normal uterine cavity and patent tubes. Patients should have normal sperm parameters (WHO, 1992) Volume: 2.0 ml or more, concentration: 20 × 106 spermatozoa per ml or more, motility: 50% motile spermatozoa, forward progression (categories ‘a’ and ‘b’) or 25% or more with rapid progression (category ‘a’), morfology: 30% or more with normal forms. Controlled ovarian stimulation protocols Three different protocols were used for controlled ovarian stimulation (Fanchin et al., 1995b, Schlaff et al., 1995): a) clomiphene citrate + HMG, b) FSH + HMG, c) GnRH-a + FSH + HMG. The choice of the protocol was determined by individual preferences of the physicians in our ovulation induction program. Clomiphene Citrate (CC) and Human Menopausal Gonadotrophin (n = 97) This ovarian stimulation protocol consisting of clomiphene citrate 100 mg daily from day 3 to 7 of the cycle, and 75 IU daily of human menopausal gonadotrophin (HMG, Humegon FD®; Organon, Oss, The Netherlands) from day 6-9 of the cycle. For some of the women, the administration of HMG was continued. In others it was increased to 150 IU, depending on the ovarian response. The ovarian response was monitored from day 10 of the cycle by vaginal ultrasound measurements of the number and diameter of follicles, the thickness and the morphology of the endometrium, and by daily measurement of serum oestradiol (E2). Human chorionic gonadotropin (HCG, Pregnyl®; Organon) 5000-10000 IU was administered when the leading follicle was 18-19 mm in diameter and 2-3 follicles of 16-17 mm were also present (serum E2 levels per follicle 18-19 mm of diameter; E2> 250pg/ml). The treatment cycles were canceled when serum oestradiol concentration exceeded 1500pg/ml or more and six follicles or more had matured. Follicle Stimulating Hormone and Human Menopausal Gonadotrophin (n=88) This protocol started with two ampoules of purified preparation of FSH ( 75IU Metrodin®; Serono Laboratories) that were administered im on cycle days 2 and 4. Ovarian stimulation was then continued with one ampoule HMG (75 IU Pergonal ® Serono Laboratories ) daily from day 6 of the cycle until the day 5000-10000 IU HCG (HCG, Profasi®; Serono Laboratories) was administered, when follicular maturity was achieved (leading follicle 18-19 mm in diameter, serum E2 levels per follicle 18-19 mm of diameter; E2> 250pg/ml). GnRH Agonist (GnRH-α) and FSH and HMG (n=17) This short protocol of GnRH-α with gonadotrophin started from cycle day 2 with daily administration of one ampoule s.c. of a GnRH-α (0.1 mg triptoreline Arvekap®; Ipsen /Biotech Laboratories, Paris, France) and continued until 10000 IU HCG (HCG, Pregnyl®; Organon) was injected. From cycle day 4 and for four days two ampoules FSH (75 IU Metrodin®; Serono Laboratories) were given. From cycle day 8, ovarian stimulation was continued with two ampoules HMG (75 IU Humegon FD®; Organon) with further individual adjustment, depending on the ovarian response until HCG injection. The follicular maturation criteria remained the same as the two preceding protocols. Randomization The women for treatment with either IUI or FSP + DNB Speculum ® were chosen at random on the day of HCG administration according to their serial number. Those with odd numbers were allocated to IUI treatment, whereas women with even numbers were allocated to FSP + DNB Spec. treatment. Sperm preparation Sexual intercourse was prohibited 2 days before (HCG) administration. The semen was collected by masturbation 2 to 3 hours before insemination. The liquefied samples were analysed using a Makler counting chamber according to World Health Organization guidelines (WHO, 1992). For sperm preparation a discontinuous two-layer Percoll gradient was used. A layer of 2.5 ml of 40% Percoll (Pharmacia Biotech AB, Upsalla, Sweden) was layered over 2.5 ml of 80% Percoll in a 15-ml conic centrifuge tube. The undiluted semen was layered over this gradient, and the tube was centrifuged for 20 minutes at 300 × g. The fluffy mass of sperm at the bottom of the 80% Percoll layer was collected by a Pasteur pipette, resuspended in 2 ml of Earle’s balanced salt solution (EBSS Gibgo BRL, Life Technologies, Paisley, Scotland) with 2% HSA, and centrifugation was repeated at 200 × g for 5 minutes. The supernatant then was discarded and the final pellet was resuspended either in 0.5ml EBSS solution with 2% HSA for standard IUI or in 4 ml for Fallopian tube Sperm Perfusion. Both solutions were also analysed. Figure 1: A. Diagram showing the DNB Speculum®, closed, clamping the cervical canal, with the modified tips (B - C) enveloping the cervix, while the insemination catheter is in the uterine cavity and the sperm suspension inseminated and perfused in the fallopian tube![]()
Insemination was in both groups performed 34 - 37 hours after HCG administration. Standard IUI was performed using a common vaginal speculum. The cervix and vaginal fornices were rinsed with normal saline solution and IUI was performed using a 1ml plastic syringe which was filled with 0.5 ml inseminate. The syringe was attached to an 18 mm insemination catheter (Wallace, UK) which was introduced into the upper part of the uterine cavity. Fallopian tube sperm perfusion was performed using the cervical clamp Double Nut Bivalve Speculum (DNB Speculum® - Figure 1,A) which was specially designed for this purpose. This cervical clamp speculun is made of non-toxic plastic, for one use only. It comprises of two rigid blades which end in slightly squared tips with rounded corners. These modified tips (Figure 1,B and C) easily grasp and clamp the cervix exerting pressure on the cervical canal. In this way the possibility of any leakage or reflux of the inseminate is prevented. The tips of the blades, which reach both the anterior and the posterior vaginal vault, are opened with the help of the first screw-nut, allowing good visibility of the cervix. At this point, with the speculum in the opening position, the 18 mm insemination catheter (Wallace, UK) is atraumatically inserted through the cervical canal into the upper part of the uterine cavity, whereas the second screw-nut is close to the posterior blade handle. Then, the first screw-nut is released and the speculum is closed by the pressure of the vaginal vault. At the same time the second nut is also released and, by pushing the handle of the anterior blade, the specially modified tips of the speculum close around the cervix and lock. A slight pressure is exerted on the clamped cervix by the enveloping, modified tips of the speculum, not at all inconvenient to the patient. At this stage exactly, with the cervix securely clamped, insemination of 4ml of the capacitated sperm is performed slowly, 2ml/min and no leaking is usually observed. The tubal ostia open up by the pressure in the uterine cavity as it gradually builds up, allowing the sperm suspension medium enter the Fallopian tubes. In this way, the number of spermatozoa is high (sperm perfusion ) throughout all the genital tract (uterine cavity, ampulla, Pouch of Douglas ) and especially at the sites where fertilization of the ovum takes place. The speculum is kept locked, clamping the cervix for five minutes at least. Luteal support The luteal phase was supported either by i.m. injections of 5000 IU HCG on days 2 and 7 after sperm insemination or by oral supplementation with 300 mg micronized progesterone (Utrogestan® Laboratories Besins Incovesco, Paris, France) Results The 104 couples with unexplained infertility enrolled in this study underwent a total of 202 cycles with either IUI or FSP + DNB Spec. The patients’ age (mean ± SD) was 31.42 ± 2.78 years (range 26-38) for group A (n=52), and 31.19 ± 2.80 years (range 24-38) for group B (n=52), the duration of infertility was 3.94 ± 1.25 (2-8) for group A, and 3.90 ± 1.24 (2-8) for group B. There was no statistical difference between the groups. On the day of randomisation (day of HCG administration) ovarian stimulation protocols (CC and HMG; FSH and HMG; GnRH-α, FSH and HMG) appeared almost homogenous in both groups (Table I). There was no difference between the two groups regarding the number of mature follicles (> 17 mm of diameter ), serum E2 levels, and the thickness of endometrium as measured by vaginal ultrasound. The total number of highly motile (graded a,b) spermatozoa, obtained after Percoll gradients, was also equivalent in both groups 44.83± 16.57 × 106 for group A and 42.68± 13.44 × 106 for group B. Clinical pregnancy was defined by the presence of fetal heart beat, detected by ultrasound examination. There were 11 pregnancies in group A (IUI) 11.95% per cycle and 21.15% per patient in four cycles, and 29 pregnancies in group B (FSP + DNB Speculum®) 26.36% per cycle and 55.76% per patient in four cycles. The differences between the two groups treated, both in pregnancy rate per cycle and pregnancy rate per patient, were statistically significant, P<0.001. One missed abortion occurred among the patients in group A (IUI) and one twin pregnancy. Three missed abortions occurred among the patients in group B (FSP + DNB Spec) as well as three twin pregnancies and two sets of quadruplets, which were reduced to twin pregnancies. Six cases of mild ovarian hyperstimulation syndrome (OHSS) occurred in both groups (Schenker, 1993). No case of moderate or severe OHSS was observed in both groups. None of the cycles in the present study was canceled for any reason.
Table I: Controlled ovarian stimulation protocols, number of follicles, serun oestradiol, endometrial thickness on day of HCG administration and number of motile spermatozoa in Groups A (IUI) and B (FSP + DNB Spec)a.
b Total number of sperm with forward progressive motility (‘a’ and ‘b’) Discussion The purpose of this prospective, randomized study was to indicate the significant improvement of pregnancy rates in couples with unexplained infertility when treated with fallopian tube sperm perfusion (inseminate 4 ml) by using the new DNB Speculum® for cervical clamp, in comparison to standard IUI (inseminate 0,5). Pregnancy rates 26.36% versus 11.95% respectively. The same protocols for controlled ovarian stimulation was used in both groups. There was not a statistically significant difference regarding the age of the patients treated, the mean number of follicles, serum E2, endometrial thickness on the day of HCG administration and the total number of motile spermatozoa inseminated. In previous studies the pregnancy rate per cycle in couples with unexplained infertility after controlled ovarian stimulation when FSP with 4 ml of inseminate was achieved by the use of different methods, has been reported to be in the range 24.1% - 40.0 % (Kahn et al., 1992, 1993a, 1993b, Li, T.C. 1993, Fanchin et al. 1995a). The results reported in this study concerning the FSP group on which the DNB Speculum® was used are similar. The pregnancy rate per cycle in cases with unexplained infertility when standard IUI was performed using a volume of 0.5 ml of inseminate has also been reported to be in the range of 5.7 - 17.7% (Evans et al., 1991; Martinez et al., 1991; Dodson and Haney,1991; Ombelet et al., 1995; Campana et al., 1996). This is comparable to the pregnancy rate of 11,95% obtained with standard IUI in the present study. Table II. The distribution of pregnancy rates per cycle after three cycles of treatment (190 cycles)
Studies on the dynamics of sperm transport have shown that there is a progressive decline in the numbers of spermatozoa along the length of the female tract, so that in normal Fallopian tubes a maximum of only 200 spermatozoa are present in the ampulla, although this number is increased to several hundreds or even thousands (maximum recorded 23000) in hydrosalpinges (Mortimer, D. 1983). Significantly greater numbers of peritoneal spermatozoa have been found after artificial insemination into the external os rather than after intercourse (Mortimer and Templeton, 1982). The number of spermatozoa recovered in the peritoneal fluid at laparoscopy after IUI was still very low, ranged from 2053 to 29450. However, the number of spermatozoa recovered in the peritoneal fluid after uterotubal flushes was significantly greater and ranged from 3500 to 9 ´ 106 (Ripps et al., 1994). Taking under serious consideration these observations, the cervical clamp Double Nut Bivalve Speculum was developed to support the method of insemination because it achieves easily and comfortably for the patient, better fallopian tube perfusion which results in higher pregnancy rates. These better results may be attributed to certain well observed and reported facts: 1. To the presence of higher concentration of motile spermatozoa around the oocytes at the site of fertilization, as well as the Pouch of Douglas. 2. To the intrauterine insemination pressure of 70-200mmHg, necessary for the achievement of perfusion and spill in normal tubes or tubes with minimal adhesions (Baker and Adamson 1995). This pressure is also necessary because in mid-follicular phase and before ovulation the endometrial glandular lumen of the fallopian tube is narrowed by some quantities of granural and membranous material (Amso et al., 1994) and by a partial tubal luminal obstruction due to the presence of tubal ostium membranes (Coemanet al., 1995). 3.To the cervical clamping, necessary to prevent the possibility of any leaking. Observations made during insemination showed that a higher volume than 0,4ml of inseminate, which fills the uterine cavity, has the tendency to reflux from the opening of the cervical canal due to the ovulation. (Franco et al., 1992). Previous studies also showed good results with intratubal insemination (Lucena et al., 1989; Berger., 1987; Oei et al, 1992). However, problems arised in the catheterization of the Fallopian tube and the possible complications associated with tubal cannulation of one of the tubes. With the FSP technique none of the above mentioned problems exist. In addition, the insemination fluid enters both Fallopian tubes, whereas tubal cannulation permits insemination of one tube only at a time. Other studies showed good results in pregnancy rates after Direct Peritoneal Insemination, rather than those obtained by standard IUI. (Forrler et al.,1986 ; Seracchioli et al., 1991; Crosignani et al., 1991). However this is an invasive method, not well tolerated by the patient. Finally, combined intra-uterine and direct intra-peritoneal insemination, has given favourable results with pregnancy rate per cycle of 30% ( Abyholm et al., 1992), but this is also an invasive method of insemination. With the use of the Double Nut Bivalve Speculum, most of the above mentioned problems are surmounted. In four cases with previous cervical cone excisions (2 knife cone, 2 Laser cone) and in 5 overweight patients the cervix had to be grasped and gently drawn to the outlet with a tenaculum. In this prospective randomized study, the results of Fallopian tube sperm perfusion when using the newly developed Cervical Clamp Double Nut Bivalve Speculum (DNB Speculum®) for both the insemination catheter insertion and the cervical clamping, are reported here. A method simple, easy to learn, inexpensive, non invasive, well tolerated, without any discomfort or bleeding, ultimately leading to far better Fallopian tube Sperm Perfusion, resulting in higher pregnancy rates than those of standard IUI. References Abyholm,T., Tanbo, T., Dale, P.O. and Magnus, O. (1992) In vivo fertilization procedures in infertile women with patent Fallopian tubes: a comparison of gamete intra-Fallopian transfer, combined intrauterine and intraperitoneal insemination, and controlled ovarian hyperstimulation alone. J. Assist. Reprod. Genet., 9, 19-23. Allen, N.C., Herbert III, C.M., Maxson, W.S., Rogers, B.J., Diamond, M.P. and Wentz, A.C. (1985) Intrauterine insemination: a critical review. Fertil. Steril., 44, 569-575. Amso, N.N., Crow, J., Lewin, J. and Shaw, R.W. (1994) A comparative morphological and ultrastructural study of endometrial gland and Fallopian tube epithelia at different stages of the menstrual cycle and the menopause. Hum. Reprod., 9, 2234-2241. Balasch, J., Ballescá, J.L., Pimentel, C., Creus, M., Fábregues, F. and Vanrell, J.A. (1994) Late low-dose pure follicle stimulating hormone for ovarian stimulation in intra-uterine insemination cycles. Hum. Reprod., 9, 1863-1866. Baker, V.L. and Adamson, G.D. (1995) Threshold intrauterine perfusion pressures for intraperitoneal spill during hydrotubation and correlation with tubal adhesive disease. Fertil. Steril., 64, 1066-1069. Berger, G. S. (1987) Intratubal insemination. Fertil. Steril., 48, 328-330. Campana, A., Sakkas, D., Stalberg, A., Bianchi, P.G., Comte, I., Pache, T. and Walker, D. (1996) Intrauterine insemination: evaluation of the results according to the woman’s age, sperm quality, total sperm count per insemination and life table analysis. Hum. Reprod., 11, 732-736. Chaffkin, L.M., Nulsen, J.C., Luciano, A.A. and Metzger, D.A. (1991) A comparative analysis of the cycle fecundity rates associated with combined human menopausal gonadotropin (hMG) and intrauterine insemination (IUI) versus either hMG or IUI alone. Fertil. Steril., 55, 252-257. Coeman, D., Belle, Y. V. and Vanderick, G. (1995) Tubal ostium membranes and their relation to infertility. Fertil. Steril., 63, 666-668. Crosignani, P.G., Ragni, G., Finzi,G.C. L., De Lauretis, L., Olivares, M.D. and Perotti, L., (1991) Intraperitoneal insemination in the treatment of male and unexplained infertility. Fertil. Steril., 55, 333-337. Dodson, W.C. and Haney, A.F. (1991) Controlled ovarian hyperstimulation and intrauterine insemination for treatment of infertility. Fertil. Steril., 55, 457-467. Evans, J., Wells, C., Gregory, L. and Walker, S. (1991) A comparison of intrauterine insemination, intraperitoneal insemination, and natural intercourse in superovulated women. Fertil. Steril. , 56, 1183-1187. Fanchin, R., Olivennes, F., Righini, C., Hazout, A., Schwab, B. and Frydman, R. (1995a) A new system for fallopian tube sperm perfusion leads to pregnancy rates twice as high as standard intrauterine insemination. Fertil. Steril. 64, 505-510. Fanchin, R., Fernandez, H., Olivennes, F. and Frydman, R. (1995b) Ovulation induction in 1995: a new policy. Hum. Reprod., 10, 2224-2225. Forrler, A., Badoc, E., Moreau, L., Dellenbach, P., Cranz, C., Clavert, A. and Rumpler, Y., (1986) Direct intraperitoneal insemination: first results confirmed. Lancet, 2, 1468. Franco Jr. J.G., Baruffi, R.L.R., Mauri, A.L. and Stone, S.C. (1992) Radiologic evaluation of incremental intrauterine instillation of contrast material. Fertil. Steril. 58, 1065-1067. Gleicher, N., Parrilli, M., Redding, L., Pratt, D. and Karande, V. (1992) Standardization of hysterosalpingography and selective salpingography: a valuable adjunct to simple opacification studies. Fertil. Steril. 58, 1136-1141. Khan, J.A., von Düring, V., Sunde, A., Sørdal, T. and Molne, K. (1992) Fallopian tube sperm perfusion. First clinical experience. Hum. Reprod. 7, 19-24. Khan, J.A., Sunde, A., Koskemies, A., von Düring, V., Sørdal, T., Christensen, F. and Molne, K. (1993a) Fallopian tube sperm perfusion (FSP) versus intra-uterine insemination (IUI) in the treatment of unexplained infertility: a prospective randomized study. Hum. Reprod. 8, 890-894. Khan, J.A., Sunde, A., von Düring, V., Sørdal, T. and Molne, K. (1993b) Treatment of unexplained infertility. Follopian tube sperm perfusion (FSP). Acta Obstet. Gynecol. Scand. 72, 193-199. Li, T.C. (1993) A simple, non-invasive method of Fallopian tube sperm perfusion. Hum. Reprod. 8, 1848-1850. Lucena, E., Ruiz, J.A., Mendoza, J.C., Ortiz, J.A., Lucena, C., Gomez, M. and Arango, A. (1989) Vaginal intratubal insemination (VITI) and vaginal GIFT, endosonographic technique: early experience. Hum. Reprod., 4, 658-662. Mamas, L. (1995a) Development of an artificial insemimation technique using the double screw bivalve speculum. IX World Congress on In Vitro Fertilization and Assisted Reproduction. Vienna (Austria), April 3-7., J. Assis. Repprod. Genet. (Supplement) 12, Abst. PP-163. Mamas, L. (1995b) Artificial insemination technique using the new double-screw bivalve speculum. ESHRE 11th Annual Meeting. Hamburg. June 28-July 1. Hum. Reprod., 10, Abst. 239 Martinez, A.R., Bernardus, R.E., Voorhorst, F.J., Vermeiden, J.P.W. and Schoemaker, J. (1991) Pregnancy rates after timed intercourse or intrauterine insemination after human menopausal gonadotropin stimulation of normal ovulatory cycles : a controlled study. Fertil. Steril., 55, 258-265. Mortimer, D. and Templeton, A.A. (1982) Sperm transport in the human female reproductive tract in relation to semen analysis characteristics and time of ovulation. J. Reprod. Fert., 64, 401-408. Mortimer, D. (1983) Sperm transport in the human female reproductive tract. Oxford Rev. Reprod. Biol., 5, pp. 30-61. Oei, M.L., Surrey, E.S., McCaleb, B. and Kerin, J.F. (1992) A prospective, randomized study of pregnancy rates after transuterotubal and intrauterine insemination. Fertil. Steril., 58, 167-171. Ombelet, W., Puttemans, P. and Bosmans, E. (1995) Intrauterine insemination: a first - step procedure in the algorithm of male subfertility treatment. Hum. Reprod., 10, Suppl. 1, 90 - 102. Pratt, D. E., Bieber, E., Barnes, R., Shangold, G., Vignovic, E. and Schreiber, J. (1991) Transvaginal intratubal insemination by tactile sensation: a preliminary report. Fertil. Steril., 56, 984-986. Ripps, B.A.,Minhas, B.S., Carson, S.A. and Buster, J.E. (1994) Intrauterine insemination in fertile women delivers larger numbers of sperm to the peritoneal fluid than intracervical insemination. Fertil. Steril., 61, 398-400. Schlaff, W., Yazigi, R., Olive, D.L., Williams, D.B., Steinkampf, M. and Odem, R.R. (1995) The empiric use of gonadotropin therapy and intrauterine insemination. Am. J. Obstet. Gynecol., 172, 778-782. Schenker, J.G (1993) Prevention and treatment of ovarian hyperstimulation . Review. Hum. Reprod. 8, 653-659. Seracchioli, R., Melega, C., Maccolini, A., Cattoli, M., Bulletti, C., Bovicceli, L., Flamigni,C. (1991) Pregnancy after direct intraperitoneal insemination. Hum. Reprod. 6, 533-536. World Health Organization (1992) WHO Laboratory Manual for the Examination of Human Semen and Semen-Cervical Mucus Interaction. 3rd edn. Cambridge University Press, Cambridge, UK.
|
|||||||||||||||||||||||||||||||||||||||||||||




Higher Pregnancy Rates


